23 January 2018 (Tuesday) - Transfusion Evidence Alert

The Transfusion Evidence Alert email came today. As always loads of information… the first one on the list was rather intriguing…

Top 10 new publications

Red blood cell transfusion in adult palliative care: a systematic review
Chin-Yee N, Taylor J, et al., Transfusion 2017

Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours
Zhang X, Chuai Y, et al. JThe Cochrane Database of Systematic Reviews 2017

Transfusion-associated necrotizing enterocolitis in preterm infants: an updated meta-analysis of observational data
Garg P, Pinotti R, et al. Journal of Perinatal Medicine 2017

Tranexamic acid for lower GI hemorrhage: a randomized placebo-controlled clinical trial
Smith SR, Murray D, et al. Diseases of the Colon and Rectum 2018

What motivates men to donate blood? A systematic review of the evidence
Carver A, Chell K, et al. Vox Sanguinis 2017

French lyophilized plasma versus fresh frozen plasma for the initial management of trauma induced coagulopathy: a randomized open-label trial
Garrigue D, Godier A, et al. Journal of Thrombosis and Haemostasis 2017

Evaluation of the advantages of platelet concentrates stored at 4 degrees C versus 22 degrees C
Yang J, Yin W, et all. Transfusion 2017.

Patients' and health care professionals' perceptions of blood transfusion: a systematic review
Abdul-Aziz B, Lorencatto F, et al. Transfusion 2017.

Cell salvage and donor blood transfusion during cesarean section: a pragmatic, multicentre randomised controlled trial (SALVO)
Khan KS, Moore PAS, et al. Plos Medicine 2017.

Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial
Ong SY, Gurrin LC, et al. The Lancet Haematology 2017.

23 January 2018 (Tuesday) - Transfusion News email

The Transfusion News people sent their email today:

Cell Salvage for Cesarean Sections January 17, 2018 Cell savage, the collection and return of lost autologous blood during surgery, is frequently used in cardiothoracic and vascular surgeries. The use of cell savage in obstetrics, however, has been limited due to the concern of amniotic fluid embolism and RhD hemolytic disease. In order to evaluate the safety and effectiveness of cell savage, 3,028 [Read More] RBC Transfusions for Palliative Care Patients January 9, 2018 Palliative care is a proactive and personalized approach for improving physical and spiritual problems in terminally ill patients. Cancer patients with symptom or treatment-related anemia heavily rely on palliative care and many receive transfusions to help alleviate their suffering. In order to assess whether red blood cell (RBC) transfusions actually improve palliative care patient’s symptoms [Read More] Successful Treatment of Refractory B-cell Lymphomas with CAR T-Cell Therapy January 3, 2018 Chimeric antigen receptor (CAR) T-cell therapy has been shown to successfully treat refractory B-cell lymphomas. Two new studies published in The New England Journal of Medicine confirm that CAR T-cell therapy can be used to treat B-cell lymphoma patients who have not responded to standard therapies. Neelapu et al. led [Read More]

23 January 2018 (Tuesday) - More CPD ?

Today I signed up to the Daily Biomedical Discovery newsletter. 

http://dbdnews.com/

It might be interesting; it might not. I shall give it a go; after all it is free. Worst case scenario I just click the "Unsubscribe" list.